@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RAWr1I53c869GMe6w8C6HaybMxQ9rgJRF4HZLZXK0ekjU> .
@prefix sub: <http://purl.org/np/RAWr1I53c869GMe6w8C6HaybMxQ9rgJRF4HZLZXK0ekjU#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:mz6nyisw&rows=> .
@prefix ns1: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubInfo ;
    a np:Nanopublication .
}
sub:assertion {
   <https://uts.nlm.nih.gov/uts/umls/concept/C0020336> ns1:use <https://uts.nlm.nih.gov/uts/umls/concept/C0087111> .
}
sub:provenance {
   sub:assertion prov:generatedAtTime "2021-12-16T20:10:43.691343"^^xsd:dateTime ;
    prov:wasGeneratedBy "S&T TWOC project version 2" .
  sub:version prov:value 2 .
  rdf:OBJECT rdfs:label "as off-label medications to treat COVID-19" .
  rdf:OBJECT-POSITION rdfs:label 246 .
  rdf:PREDICATE rdfs:label "used" .
  rdf:PREDICATE-POSITION rdfs:label "[189]" .
  rdf:SUBJECT rdfs:label "Certain medications , for example , dexamethasone , antimalarials ( chloroquine / hydroxychloroquine ) , antiviral ( remdesivir ) , and IL-6 receptor blocking monoclonal antibodies ( tocilizumab )" .
  rdf:SUBJECT-POSITION rdfs:label 81 .
  rdfs:ABSTRACT-UID ns2:50 "mz6nyisw" .
  rdfs:SENTENCE rdfs:label "Certain medications, for example, dexamethasone, antimalarials (chloroquine/hydroxychloroquine), antiviral (remdesivir), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), are used in various combinations as off-label medications to treat COVID-19." .
  rdfs:TRIPLE-UID ns3:mz6nyisw-TRIPLE-ABSTRACT-1 "mz6nyisw-TRIPLE-ABSTRACT-1" .
  <https://uts.nlm.nih.gov/uts/umls/concept/C0020336> rdfs:label "hydroxychloroquine" .
  <https://uts.nlm.nih.gov/uts/umls/concept/C0087111> rdfs:label "treat" .
}
sub:pubInfo {
   sub:assertion prov:wasDerivedFrom <https://doi.org/10.1007/s10787-020-00744-0> .
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" ;
    npx:hasSignature "d/ey03oP1SlHTw5+ugb3nZ7YHta7mgI7tG6LG1u3raa0+wkyhPHGXZ+CHTiyDM5HlnOdyJWyY5OnxpZY59rgmHMAOahvqaNBJuf2DcBYExAs9aH6fo+u+E4l3FWYmViAu3cmABYWHkANwKmXfHkHHtXVbA8Rzuir+xyIFtATh+4=" ;
    npx:hasSignatureTarget this: .
  this: prov:generatedAtTime "2021-12-16T20:10:43.691343"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}